Gene · 900
Papers2,141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,141
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DNMT2/TRDMT1 gene knockout compromises doxorubicin-induced unfolded protein response and sensitizes cancer cells to ER stress-induced apoptosis. | Apoptosis | 2023 | 36273376 | PubTator, text mining | PubMed |
| Concomitant targeting of FLT3 and BTK overcomes FLT3 inhibitor resistance in acute myeloid leukemia through the inhibition of autophagy. | Haematologica | 2023 | 36226489 | PubTator, text mining | PubMed |
| MS4A3-HSP27 target pathway reveals potential for haematopoietic disorder treatment in alimentary toxic aleukia. | Cell Biol Toxicol | 2023 | 34581912 | PubTator, text mining | PubMed |
Three year results of Blessed: Expanded access for DeltaRex-G for an intermediate size population with advanced pancreatic cancer and sarcoma (NCT04091295) and individual patient use of DeltaRex-G for solid malignancies (IND# 19130). | Front Mol Med | 2022 | 39086973 | PubTator, text mining | PubMed |
| Virus-like nanoparticles as a theranostic platform for cancer. | Front Bioeng Biotechnol | 2022 | 36714624 | PubTator, text mining | PubMed |
Transcriptomic Analysis of the Effect of Metformin against Cisplatin-Induced Ototoxicity: A Potential Mechanism of Metformin-Mediated Inhibition of Thioredoxin-Interacting Protein (Txnip) Gene Expression. | Curr Issues Mol Biol | 2022 | 36661507 | PubTator, text mining | PubMed |
| Expressional and functional characteristics of checkpoint kinase 1 as a prognostic biomarker in hepatocellular carcinoma. | Transl Cancer Res | 2022 | 36644193 | PubTator, text mining | PubMed |
| Co3O4@NiMoO4 composite electrode materials for flexible hybrid capacitors. | Front Optoelectron | 2022 | 36637574 | PubTator, text mining | PubMed |
| Prediction of Survival and Tumor Microenvironment Infiltration Based on Pyroptosis-Related lncRNAs in Pancreatic Cancer. | Dis Markers | 2022 | 36618967 | PubTator, text mining | PubMed |
| Role of microRNA-regulated cancer stem cells in recurrent hepatocellular carcinoma. | World J Hepatol | 2022 | 36618329 | PubTator, text mining | PubMed |
| Mechanism of Hypoxia-Mediated Smooth Muscle Cell Proliferation Leading to Vascular Remodeling. | Biomed Res Int | 2022 | 36593773 | PubTator, text mining | PubMed |
| Differential expression of cyclins CCNB1 and CCNG1 is involved in the chondrocyte damage of kashin-beck disease. | Front Genet | 2022 | 36588792 | PubTator, text mining | PubMed |
| Circulating messenger RNA variants as a potential biomarker for surveillance of hepatocellular carcinoma. | Front Oncol | 2022 | 36582804 | PubTator, text mining | PubMed |
| Dual roles and potential applications of exosomes in HCV infections. | Front Microbiol | 2022 | 36578571 | PubTator, text mining | PubMed |
| Reactivating commuter cycling: COVID-19 pandemic disruption to everyday transport choices in Sydney, Australia. | J Transp Geogr | 2022 | 36568878 | PubTator, text mining | PubMed |
| Transcutaneous Functional Electrical Stimulation Controlled by a System of Sensors for the Lower Limbs: A Systematic Review. | Sensors (Basel) | 2022 | 36560179 | PubTator, text mining | PubMed |
| Aqueous Rechargeable Zn/ZnO Battery Based on Deposition/Dissolution Chemistry. | Molecules | 2022 | 36557797 | PubTator, text mining | PubMed |
| Receptor-Mediated Redox Imbalance: An Emerging Clinical Avenue against Aggressive Cancers. | Biomolecules | 2022 | 36551308 | PubTator, text mining | PubMed |
| Cellular features of localized microenvironments in human meniscal degeneration: a single-cell transcriptomic study. | Elife | 2022 | 36548025 | PubTator, text mining | PubMed |
| Single-cell transcriptome reveals core cell populations and androgen-RXFP2 axis involved in deer antler full regeneration. | Cell Regen | 2022 | 36542206 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/900/papers?page=11